View the Show Notes Page for This Episode

Become a Member to Receive Exclusive Content

Sign Up to Receive Peter's Weekly Newsletter

In this episode, Peter takes a deep dive into the science and application of aging clocks, unpacking what they are, the differences between chronological age, biological age, and the pace of aging, and what epigenetic clocks may actually be measuring. He explores key research in the field, including a randomized controlled trial that tested simple lifestyle interventions against several commonly used aging clocks, as well as a study using brain MRI to assess the pace of aging and its relationship to dementia risk and mortality. Throughout the episode, Peter highlights the promises and pitfalls of these tools, ultimately focusing on the field's central question: whether improving an aging clock score truly translates into meaningful clinical outcomes.

We discuss:

• Why aging clocks are being used as proxies for long-term health outcomes and the uncertainty surrounding their clinical value [2:00];

• How aging clocks use DNA methylation to predict age and how they compare to traditional mortality prediction models [5:00];

• The shift from aging clocks that predict chronological age to newer models that aim to measure biological age, lifespan differences, and the pace of aging [11:45];

• The limitations of second-generation aging clocks: biological and measurement noise affecting reliability and interpretation [14:45];

• Why aging clocks are exciting tools—compression, speed, and individual feedback [17:15];

• The DO-HEALTH randomized trial: the study design and how different aging clocks were used to measure biological age and the pace of aging [22:00];

• The DO-HEALTH study results: findings, takeaways, and open questions [27:45];

• The DunedinPACNI study: how the model was developed and what it may add to the field [35:00];

• The promise and limitations of aging clocks in measuring meaningful biological aging and predicting health outcomes [48:00];

• Why aging clocks are not yet reliable as consumer tools and why traditional health metrics still matter most [52:00]; and

• More.

Connect With Peter on Twitter, Instagram,